External validation of the SOX-PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis.
External validation of the SOX-PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis.
复制标题
DOI:
10.1111/jth.14791
复制
发表时间:
2020-06
期刊:
影响因子:
--
通讯作者:
ATTRACT Trial Investigators
中科院分区:
文献类型:
--
作者:
Rabinovich A;Gu CS;Vedantham S;Kearon C;Goldhaber SZ;Gornik HL;Kahn SR;ATTRACT Trial Investigators
Using data from the SOX Trial, we recently developed a clinical prediction model for occurrence of the post-thrombotic syndrome (PTS) after proximal deep vein thrombosis (DVT), termed the SOX-PTS score. The score includes anatomical extent of DVT; body mass index; and baseline Villalta score. To externally validate the SOX-PTS score. Logistic regression analysis of data from the ATTRACT Trial which evaluated pharmacomechanical catheter directed thrombolysis in patients with proximal DVT. The primary outcome was the occurrence of PTS (defined as Villalta score ≥ 5) from 6 to 24 months after DVT. Secondary outcomes included moderate-severe PTS (Villalta scale ≥ 10) and severe PTS (Villalta scale ≥ 14). Predictive performance was assessed by discrimination and calibration. An updated score was evaluated in an exploratory analysis. 691 ATTRACT patients were included, of whom 328 (47%) developed PTS. The c-statistic was 0.63; 95% confidence interval (CI) 0.59-0.67 for PTS. The model's performance appeared to be better for the outcomes moderate to severe PTS and severe PTS (c-statistic 0.67; 95% CI 0.62 to 0.72 for moderate-severe PTS and 0.70; 0.64 to 0.77 for severe PTS). An updated model with age as an additional variable performed similarly to the original model. We externally validated the SOX-PTS score for estimating the risk of developing PTS, moderate to severe PTS, and severe PTS, in patients with proximal DVT. The score may be useful to predict PTS at the time of DVT diagnosis. Further external validation in different patient cohorts is required.
登录
查看更多内容
DOI:
10.1056/nejmoa1615066
发表时间:
2017-12-07
期刊:
The New England journal of medicine
影响因子:
--
作者:
Vedantham S;Goldhaber SZ;Julian JA;Kahn SR;Jaff MR;Cohen DJ;Magnuson E;Razavi MK;Comerota AJ;Gornik HL;Murphy TP;Lewis L;Duncan JR;Nieters P;Derfler MC;Filion M;Gu CS;Kee S;Schneider J;Saad N;Blinder M;Moll S;Sacks D;Lin J;Rundback J;Garcia M;Razdan R;VanderWoude E;Marques V;Kearon C;ATTRACT Trial Investigators
通讯作者:
ATTRACT Trial Investigators
影响因子:
9.6
作者:
Kearon, Clive;Akl, Elie A.;Moores, Lisa
通讯作者:
Moores, Lisa
DOI:
10.1016/j.jvir.2014.04.019
发表时间:
2014-09-01
影响因子:
2.9
作者:
Vedantham, Suresh;Sista, Akhilesh K.;Nikolic, Boris
通讯作者:
Nikolic, Boris
影响因子:
6.7
作者:
Amin, Elham E.;van Kuijk, Sander M. J.;ten Cate-Hoek, Arina J.
通讯作者:
ten Cate-Hoek, Arina J.
DOI:
10.1111/j.2517-6161.1977.tb01600.x
发表时间:
1977-01-01
期刊:
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-METHODOLOGICAL
影响因子:
--
作者:
DEMPSTER, AP;LAIRD, NM;RUBIN, DB
通讯作者:
RUBIN, DB